Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1997 Oct;90(10):533–539. doi: 10.1177/014107689709001003

Precursor lesions for prostate cancer.

M R Feneley 1, C Busch 1
PMCID: PMC1296593  PMID: 9488009

Full text

PDF
533

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aboseif S., Shinohara K., Weidner N., Narayan P., Carroll P. R. The significance of prostatic intra-epithelial neoplasia. Br J Urol. 1995 Sep;76(3):355–359. doi: 10.1111/j.1464-410x.1995.tb07714.x. [DOI] [PubMed] [Google Scholar]
  2. Alexander E. E., Qian J., Wollan P. C., Myers R. P., Bostwick D. G. Prostatic intraepithelial neoplasia does not appear to raise serum prostate-specific antigen concentration. Urology. 1996 May;47(5):693–698. doi: 10.1016/s0090-4295(96)00004-0. [DOI] [PubMed] [Google Scholar]
  3. Allam C. K., Bostwick D. G., Hayes J. A., Upton M. P., Wade G. G., Domanowski G. F., Klein M. A., Boling E. A., Stilmant M. M. Interobserver variability in the diagnosis of high-grade prostatic intraepithelial neoplasia and adenocarcinoma. Mod Pathol. 1996 Jul;9(7):742–751. [PubMed] [Google Scholar]
  4. Bartels P. H., Thompson D., Montironi R., Mariuzzi G., Hamilton P. W. Automated reasoning system in histopathologic diagnosis and prognosis of prostate cancer and its precursors. Eur Urol. 1996;30(2):222–233. doi: 10.1159/000474173. [DOI] [PubMed] [Google Scholar]
  5. Bonkhoff H., Remberger K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate. 1996 Feb;28(2):98–106. doi: 10.1002/(SICI)1097-0045(199602)28:2<98::AID-PROS4>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  6. Bonkhoff H., Remberger K. Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch A Pathol Anat Histopathol. 1993;422(1):35–38. doi: 10.1007/BF01605130. [DOI] [PubMed] [Google Scholar]
  7. Bonkhoff H., Stein U., Remberger K. Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells. Hum Pathol. 1995 Feb;26(2):167–170. doi: 10.1016/0046-8177(95)90033-0. [DOI] [PubMed] [Google Scholar]
  8. Bonkhoff H., Stein U., Remberger K. The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate. 1994;24(3):114–118. doi: 10.1002/pros.2990240303. [DOI] [PubMed] [Google Scholar]
  9. Bostwick D. G., Amin M. B., Dundore P., Marsh W., Schultz D. S. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol. 1993 Mar;24(3):298–310. doi: 10.1016/0046-8177(93)90041-e. [DOI] [PubMed] [Google Scholar]
  10. Bostwick D. G., Burke H. B., Wheeler T. M., Chung L. W., Bookstein R., Pretlow T. G., Nagle R. B., Montironi R., Lieber M. M., Veltri R. W. The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials. J Cell Biochem Suppl. 1994;19:283–289. [PubMed] [Google Scholar]
  11. Bostwick D. G., Pacelli A., Lopez-Beltran A. Molecular biology of prostatic intraepithelial neoplasia. Prostate. 1996 Aug;29(2):117–134. doi: 10.1002/(SICI)1097-0045(199608)29:2<117::AID-PROS7>3.0.CO;2-C. [DOI] [PubMed] [Google Scholar]
  12. Bostwick D. G., Qian J. Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies. Am J Surg Pathol. 1995 May;19(5):506–518. doi: 10.1097/00000478-199505000-00002. [DOI] [PubMed] [Google Scholar]
  13. Bostwick D. G., Qian J., Frankel K. The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies. J Urol. 1995 Nov;154(5):1791–1794. [PubMed] [Google Scholar]
  14. Brawer M. K., Bigler S. A., Sohlberg O. E., Nagle R. B., Lange P. H. Significance of prostatic intraepithelial neoplasia on prostate needle biopsy. Urology. 1991 Aug;38(2):103–107. doi: 10.1016/s0090-4295(05)80067-6. [DOI] [PubMed] [Google Scholar]
  15. Brawer M. K., Rennels M. A., Nagle R. B., Soiderer M. H., Lee F. Prostatic intraepithelial neoplasia: a lesion that may be confused with cancer on prostatic ultrasound. J Urol. 1989 Dec;142(6):1510–1512. doi: 10.1016/s0022-5347(17)39142-5. [DOI] [PubMed] [Google Scholar]
  16. Brawn P. N., Johnson E. H., Speights V. O., Riggs M., Lind M., Bell N. Long-term survival of stage A prostate carcinoma, atypical hyperplasia/adenosis and BPH. Br J Cancer. 1994 Jun;69(6):1098–1101. doi: 10.1038/bjc.1994.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Brolin J., Skoog L., Ekman P. Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue. Prostate. 1992;20(4):281–295. doi: 10.1002/pros.2990200404. [DOI] [PubMed] [Google Scholar]
  18. Budillon A. Molecular genetics of cancer. Oncogenes and tumor suppressor genes. Cancer. 1995 Nov 15;76(10):1869–1873. doi: 10.1002/1097-0142(19951115)76:10<1869::aid-cncr2820761030>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  19. Colombel M., Symmans F., Gil S., O'Toole K. M., Chopin D., Benson M., Olsson C. A., Korsmeyer S., Buttyan R. Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers. Am J Pathol. 1993 Aug;143(2):390–400. [PMC free article] [PubMed] [Google Scholar]
  20. Davidson D., Bostwick D. G., Qian J., Wollan P. C., Oesterling J. E., Rudders R. A., Siroky M., Stilmant M. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J Urol. 1995 Oct;154(4):1295–1299. [PubMed] [Google Scholar]
  21. Davies P., Eaton C. L. Regulation of prostate growth. J Endocrinol. 1991 Oct;131(1):5–17. doi: 10.1677/joe.0.1310005. [DOI] [PubMed] [Google Scholar]
  22. Emmert-Buck M. R., Vocke C. D., Pozzatti R. O., Duray P. H., Jennings S. B., Florence C. D., Zhuang Z., Bostwick D. G., Liotta L. A., Linehan W. M. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. Cancer Res. 1995 Jul 15;55(14):2959–2962. [PubMed] [Google Scholar]
  23. Epstein J. I., Grignon D. J., Humphrey P. A., McNeal J. E., Sesterhenn I. A., Troncoso P., Wheeler T. M. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol. 1995 Aug;19(8):873–886. doi: 10.1097/00000478-199508000-00002. [DOI] [PubMed] [Google Scholar]
  24. Feigl P., Blumenstein B., Thompson I., Crowley J., Wolf M., Kramer B. S., Coltman C. A., Jr, Brawley O. W., Ford L. G. Design of the Prostate Cancer Prevention Trial (PCPT). Control Clin Trials. 1995 Jun;16(3):150–163. doi: 10.1016/0197-2456(94)00xxx-m. [DOI] [PubMed] [Google Scholar]
  25. Ferguson J., Zincke H., Ellison E., Bergstrahl E., Bostwick D. G. Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy. Urology. 1994 Jul;44(1):91–95. doi: 10.1016/s0090-4295(94)80015-4. [DOI] [PubMed] [Google Scholar]
  26. Garnett J. E., Oyasu R. Urologic evaluation of atypical prostatic hyperplasia. Urology. 1989 Dec;34(6 Suppl):66–69. [PubMed] [Google Scholar]
  27. Gobbi P. G., Dionigi P., Barbieri F., Corbella F., Bertoloni D., Grignani G., Jemos V., Pieresca C., Ascari E. The role of surgery in the multimodal treatment of primary gastric non-Hodgkin's lymphomas. A report of 76 cases and review of the literature. Cancer. 1990 Jun 1;65(11):2528–2536. doi: 10.1002/1097-0142(19900601)65:11<2528::aid-cncr2820651123>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  28. Gormley G. J. Chemoprevention strategies for prostate cancer: the role of 5 alpha-reductase inhibitors. J Cell Biochem Suppl. 1992;16H:113–117. doi: 10.1002/jcb.240501226. [DOI] [PubMed] [Google Scholar]
  29. Hellström M., Häggman M., Brändstedt S., de la Torre M., Pedersen K., Jarlsfeldt I., Wijkström H., Busch C. Histopathological changes in androgen-deprived localized prostatic cancer. A study in total prostatectomy specimens. Eur Urol. 1993;24(4):461–465. doi: 10.1159/000474350. [DOI] [PubMed] [Google Scholar]
  30. Isaacs W. B., Bova G. S., Morton R. A., Bussemakers M. J., Brooks J. D., Ewing C. M. Molecular biology of prostate cancer. Semin Oncol. 1994 Oct;21(5):514–521. [PubMed] [Google Scholar]
  31. Keetch D. W., Humphrey P., Stahl D., Smith D. S., Catalona W. J. Morphometric analysis and clinical followup of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate. J Urol. 1995 Aug;154(2 Pt 1):347–351. doi: 10.1097/00005392-199508000-00003. [DOI] [PubMed] [Google Scholar]
  32. Kovi J., Mostofi F. K., Heshmat M. Y., Enterline J. P. Large acinar atypical hyperplasia and carcinoma of the prostate. Cancer. 1988 Feb 1;61(3):555–561. doi: 10.1002/1097-0142(19880201)61:3<555::aid-cncr2820610322>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  33. Krajewska M., Krajewski S., Epstein J. I., Shabaik A., Sauvageot J., Song K., Kitada S., Reed J. C. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol. 1996 May;148(5):1567–1576. [PMC free article] [PubMed] [Google Scholar]
  34. Langer J. E., Rovner E. S., Coleman B. G., Yin D., Arger P. H., Malkowicz S. B., Nisenbaum H. L., Rowling S. E., Tomaszewski J. E., Wein A. J. Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy. J Urol. 1996 Jan;155(1):228–231. [PubMed] [Google Scholar]
  35. Lee F., Torp-Pedersen S. T., Carroll J. T., Siders D. B., Christensen-Day C., Mitchell A. E. Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia. Urology. 1989 Dec;34(6 Suppl):4–8. [PubMed] [Google Scholar]
  36. Markham C. W. Prostatic intraepithelial neoplasia: detection and correlation with invasive cancer in fine-needle biopsy. Urology. 1989 Dec;34(6 Suppl):57–61. [PubMed] [Google Scholar]
  37. McNeal J. E., Bostwick D. G. Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol. 1986 Jan;17(1):64–71. doi: 10.1016/s0046-8177(86)80156-3. [DOI] [PubMed] [Google Scholar]
  38. McNeal J. E., Villers A., Redwine E. A., Freiha F. S., Stamey T. A. Microcarcinoma in the prostate: its association with duct-acinar dysplasia. Hum Pathol. 1991 Jul;22(7):644–652. doi: 10.1016/0046-8177(91)90286-x. [DOI] [PubMed] [Google Scholar]
  39. Montironi R., Bostwick D. G., Bonkhoff H., Cockett A. T., Helpap B., Troncoso P., Waters D. Origins of prostate cancer. Cancer. 1996 Jul 15;78(2):362–365. doi: 10.1002/(SICI)1097-0142(19960715)78:2<362::AID-CNCR28>3.0.CO;2-T. [DOI] [PubMed] [Google Scholar]
  40. Montironi R., Galluzzi C. M., Diamanti L., Giannulis I., Pisani E., Scarpelli M. Prostatic intra-epithelial neoplasia: expression and location of proliferating cell nuclear antigen in epithelial, endothelial and stromal nuclei. Virchows Arch A Pathol Anat Histopathol. 1993;422(3):185–192. doi: 10.1007/BF01621801. [DOI] [PubMed] [Google Scholar]
  41. Montironi R., Galluzzi C. M., Diamanti L., Taborro R., Scarpelli M., Pisani E. Prostatic intra-epithelial neoplasia. Qualitative and quantitative analyses of the blood capillary architecture on thin tissue sections. Pathol Res Pract. 1993 Jun;189(5):542–548. [PubMed] [Google Scholar]
  42. Montironi R., Magi Galluzzi C. M., Marina S., Diamanti L. Quantitative characterization of the frequency and location of cell proliferation and death in prostate pathology. J Cell Biochem Suppl. 1994;19:238–245. [PubMed] [Google Scholar]
  43. Myers R. B., Oelschlager D., Srivastava S., Grizzle W. E. Accumulation of the p53 protein occurs more frequently in metastatic than in localized prostatic adenocarcinomas. Prostate. 1994 Nov;25(5):243–248. doi: 10.1002/pros.2990250504. [DOI] [PubMed] [Google Scholar]
  44. Norlén B. J. Swedish randomized trial of radical prostatectomy versus watchful waiting. Can J Oncol. 1994 Nov;4 (Suppl 1):38–42. [PubMed] [Google Scholar]
  45. Qian J., Bostwick D. G., Takahashi S., Borell T. J., Herath J. F., Lieber M. M., Jenkins R. B. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res. 1995 Nov 15;55(22):5408–5414. [PubMed] [Google Scholar]
  46. Qian J., Bostwick D. G. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens. Pathol Res Pract. 1995 Sep;191(9):860–867. doi: 10.1016/S0344-0338(11)80969-6. [DOI] [PubMed] [Google Scholar]
  47. Raviv G., Janssen T., Zlotta A. R., Descamps F., Verhest A., Schulman C. C. Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer. J Urol. 1996 Sep;156(3):1050–1055. doi: 10.1016/s0022-5347(01)65699-4. [DOI] [PubMed] [Google Scholar]
  48. Sakr W. A., Grignon D. J., Haas G. P., Heilbrun L. K., Pontes J. E., Crissman J. D. Age and racial distribution of prostatic intraepithelial neoplasia. Eur Urol. 1996;30(2):138–144. doi: 10.1159/000474163. [DOI] [PubMed] [Google Scholar]
  49. Sakr W. A., Macoska J. A., Benson P., Grignon D. J., Wolman S. R., Pontes J. E., Crissman J. D. Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res. 1994 Jun 15;54(12):3273–3277. [PubMed] [Google Scholar]
  50. Schröder F. H., Denis L. J., Kirkels W., de Koning H. J., Standaert B. European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies. Cancer. 1995 Jul 1;76(1):129–134. doi: 10.1002/1097-0142(19950701)76:1<129::aid-cncr2820760120>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  51. Troncoso P., Babaian R. J., Ro J. Y., Grignon D. J., von Eschenbach A. C., Ayala A. G. Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens. Urology. 1989 Dec;34(6 Suppl):52–56. [PubMed] [Google Scholar]
  52. Weinstein M. H., Epstein J. I. Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy. Hum Pathol. 1993 Jun;24(6):624–629. doi: 10.1016/0046-8177(93)90242-9. [DOI] [PubMed] [Google Scholar]
  53. Westin P., Stattin P., Damber J. E., Bergh A. Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors. Am J Pathol. 1995 Jun;146(6):1368–1375. [PMC free article] [PubMed] [Google Scholar]
  54. Wilt T. J., Brawer M. K. The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J Urol. 1994 Nov;152(5 Pt 2):1910–1914. doi: 10.1016/s0022-5347(17)32413-8. [DOI] [PubMed] [Google Scholar]
  55. de la Torre M., Häggman M., Brändstedt S., Busch C. Prostatic intraepithelial neoplasia and invasive carcinoma in total prostatectomy specimens: distribution, volumes and DNA ploidy. Br J Urol. 1993 Aug;72(2):207–213. doi: 10.1111/j.1464-410x.1993.tb00689.x. [DOI] [PubMed] [Google Scholar]
  56. di Sant'Agnese P. A. Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications. Cancer. 1992 Jul 1;70(1 Suppl):254–268. doi: 10.1002/1097-0142(19920701)70:1+<254::aid-cncr2820701312>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES